Reaction
Perirectal Abscess reporting signals
As of the last recalculation, Perirectal Abscess appears in 1,102 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is ISOTRETINOIN (PRR 59.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Isotretinoin | 137 | 59.6 | 59.8 |
| Pegaspargase | 20 | 31.4 | 31.5 |
| Mercaptopurine | 24 | 26.7 | 26.7 |
| Meperidine Hydrochloride | 12 | 24.9 | 24.9 |
| Piperacillin Sodium And Tazobactam Sodium | 24 | 23.6 | 23.6 |
| Metronidazole | 68 | 21.4 | 21.4 |
| Dextrose | 14 | 20.3 | 20.3 |
| Dextrose Monohydrate | 14 | 20.0 | 20.0 |
| Ciprofloxacin Hydrochloride And Hydrocortisone | 20 | 18.5 | 18.5 |
| Diphenoxylate Hydrochloride And Atropine Sulfate | 13 | 18.1 | 18.1 |
| Polyethylene Glycol | 9 | 15.8 | 15.8 |
| Clindamycin Phosphate | 27 | 15.6 | 15.6 |
| Sennosides 8.6 Mg Tablets | 16 | 14.6 | 14.6 |
| Senna | 16 | 14.5 | 14.5 |
| Mupirocin | 10 | 14.1 | 14.1 |
| Leucovorin Calcium | 14 | 14.0 | 14.0 |
| Mupirocin Calcium | 10 | 13.9 | 13.9 |
| Cefepime | 10 | 13.3 | 13.3 |
| Cytarabine | 40 | 13.0 | 13.0 |
| Cefepime Hydrochloride | 10 | 11.8 | 11.8 |
| Mesalamine | 34 | 11.8 | 11.8 |
| Bevacizumab | 58 | 9.3 | 9.3 |
| Canagliflozin | 14 | 8.9 | 8.9 |
| Vedolizumab | 38 | 8.6 | 8.6 |
| Rocuronium Bromide | 5 | 8.0 | 8.0 |
| Certolizumab Pegol | 37 | 6.1 | 6.1 |
| Polatuzumab Vedotin | 3 | 5.8 | 5.8 |
| Adapalene | 3 | 0.3 | 0.3 |